-- 根據週四提交給澳洲證券交易所的文件,Clarity Pharmaceuticals(ASX:CU6)在與美國食品藥物管理局(FDA)成功舉行階段結束會議後,將啟動一項針對神經內分泌腫瘤的銅-64-SARTATE的註冊性3期臨床試驗。 該公司計劃招募約70名受試者參與試驗。 文件還顯示,Clarity正在美國和澳洲招募受試者,進行一項針對高風險前列腺癌患者在根治性前列腺切除術前使用銅-64-SAR-bisPSMA進行正電子發射斷層掃描(PET)成像的註冊性3期臨床試驗。該公司計劃招募約383名受試者。 文件稱,該試驗將評估銅-64-SAR-bisPSMA PET在檢測骨盆腔淋巴結內前列腺癌的診斷效能。 Clarity Pharmaceuticals的股價在周四的交易中下跌了近2%。
Related Articles
Yangtze Optical Fibre's Profit Soars 226% in Q1
Yangtze Optical Fibre and Cable's (SHA:601869, HKG:6869) recorded a 226% rise in attributable profit in the first quarter of 2026 to 495.1 million yuan from 151.7 million yuan a year prior, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the Chinese cable manufacturer were down over 12% in Thursday afternoon trading while China-listed shares were down 4%.Earnings per share rose to 0.60 yuan from 0.20 yuan in the corresponding period of the previous fiscal year.Operating income surged 28% to 3.7 billion yuan from 2.89 billion yuan in the year-ago period.
Australian Shares Extend Losing Streak; Woolworths Group Reports Higher Fiscal Q3 Sales
Australian shares extended their losing streak for the eighth consecutive day on Thursday's close as the US continued its naval blockade of Iranian ports.The S&P/ASX 200 Index retreated 0.24%, or by 21.20 points, to close at 8,665.80.Brent crude oil futures jumped 5.2% to $124.15 per barrel. The Strait of Hormuz remained closed, as US President Donald Trump is reported to be considering military options as the deadlock in negotiations with Iran continues, according to an Axios report as cited by Reuters.On the domestic front, Australia's export prices rose 0.5% in the March quarter after a 3.2% increase in the December 2025 quarter, while import prices rose 0.1% after a 0.9% increase in the previous quarter, data from the Australian Bureau of Statistics showed.Australia's total credit rose 0.7% month on month in March, following a 0.6% increase in February, data from the Reserve Bank of Australia showed.Small businesses in Australia had a firm start to the year, with the March quarter recording a 7.2% jump in sales, though higher fuel prices amid the Middle East conflict present a key risk, Xero said. Sales, jobs, and wages all grew during the quarter, nearly reaching their historical average growth rates.In company news, Woolworths Group (ASX:WOW) reported fiscal third-quarter sales of about AU$18.1 billion, up 4.5% from AU$17.31 billion in the year-ago period. Reported fiscal 2026 Australian food earnings before interest and taxes growth is still expected to be in the mid to high single-digit range, but no longer at the upper end of the range. Its shares fell 7% at market close.Mineral Resources' (ASX:MIN) fiscal third-quarter production volume reached 80 million wet metric tonnes (wmt), up from 62 million wmt a year earlier. Total iron ore production for the three months ended March 31 across Onslow Iron and the Pilbara Hub was 10.3 million wmt, with shipments totaling 9.3 million wmt. Its shares closed up 2%.Lastly, ASX (ASX:ASX) appointed Darren Yip, group executive of markets and listings, as interim chief executive, succeeding Helen Lofthouse, effective May 29. Its shares also closed up 2%.
Singapore's Export, Import Prices Rise in March
Singapore's Export Price Index rose 8.4% year on year in March, reversing a 4.2% decline in the preceding month, the city-state's Department of Statistics reported Thursday.The Non-Oil Index gained 0.2%, while the Oil Index surged 44.5% on year during the month.Meanwhile, the Import Price Index rose 11.1% year on year in March, after a 1.3% decline in the preceding month.The Non-Oil Index rose 2.3% and the Oil Index surged 41.5% on year, the data showed.On a month-on-month basis, the Export Price Index rose 11.7%, while the Import Price Index rose 11.2%, the data showed.